Vitamin Blue, Inc.
VTMB · OTC
6/30/2018 | 3/31/2018 | 12/31/2017 | 9/30/2017 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.36 | -0.00 | 4.23 | 1.14 |
| FCF Yield | 0.24% | -0.21% | 0.02% | 0.17% |
| EV / EBITDA | -111.86 | -67.46 | -3,383.43 | 820.17 |
| Quality | ||||
| ROIC | 3.94% | 4.67% | 2.26% | 0.50% |
| Gross Margin | 23.13% | 32.47% | 35.97% | 36.75% |
| Cash Conversion Ratio | -0.18 | 0.06 | -1.99 | -0.29 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.52% | 20.38% | 22.18% | 22.13% |
| Free Cash Flow Growth | 348.11% | -857.14% | -87.27% | 233.33% |
| Safety | ||||
| Net Debt / EBITDA | -14.61 | -16.84 | -747.02 | 163.40 |
| Interest Coverage | -1.95 | -2.43 | 0.00 | -0.33 |
| Efficiency | ||||
| Inventory Turnover | 3.33 | 3.03 | 4.07 | 4.07 |
| Cash Conversion Cycle | -321.22 | -334.36 | -237.96 | -184.96 |